Get startedLog in
    Picture of Paradigm Biopharmaceuticals logo

    PAR — Paradigm Biopharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    All News

    Australia Stock Exchange release from PARADIGM BIOPHAR : UK ethics and regulatory approval for Phase 3 study

    Picture of Paradigm Biopharmaceuticals logoParadigm Biopharmaceuticals
    16/03/2022 22:20
    Australia Stock Exchange release from PARADIGM BIOPHAR  PAR.AX : UK ethics and regulatory approval for Phase 3 study

    Recent news on Paradigm Biopharmaceuticals

    See all news